Detalhe da pesquisa
1.
Primary tumor type prediction based on US nationwide genomic profiling data in 13,522 patients.
Comput Struct Biotechnol J
; 21: 3865-3874, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37593720
2.
Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma.
Cancer Cell
; 41(4): 791-806.e4, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37037616
3.
Real-world data prognostic model of overall survival in patients with advanced NSCLC receiving anti-PD-1/PD-L1 immune checkpoint inhibitors as second-line monotherapy.
Cancer Rep (Hoboken)
; 5(10): e1578, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35075804
4.
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial.
Nat Med
; 28(6): 1167-1177, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35662283